EMTRICITABINE+TENOFOVIR DISOPROXIL FUMARATE+EFAVIRENZ
About EMTRICITABINE+TENOFOVIR DISOPROXIL FUMARATE+EFAVIRENZ
EMTRICITABINE+TENOFOVIR DISOPROXIL FUMARATE+EFAVIRENZ belongs to the class of medicines called ‘antiretroviral agents’ used to treat HIV infection. HIV is a virus that attacks the immune cells of the body leading to decreased immunity. It spreads through body fluids such as semen, vaginal fluid, and blood. Symptoms include fever, chills, rash, night sweats, muscle aches, tiredness, and sore throat that usually last for days to several weeks.
EMTRICITABINE+TENOFOVIR DISOPROXIL FUMARATE+EFAVIRENZ contains Emtricitabine, Tenofovir Disoproxil Fumarate and Efavirenz. Efavirenz is a non-nucleoside reverse transcriptase inhibitor, Emtricitabine is a nucleoside reverse transcriptase inhibitor, and Tenofovir Disoproxil Fumarate is a nucleotide reverse transcriptase inhibitor. They work by inhibiting the reverse transcriptase enzyme production, which is necessary for the multiplication of the viruses. This effect helps to inhibit viral replication.
You should take this medicine exactly as prescribed by the doctor. The common side-effects of EMTRICITABINE+TENOFOVIR DISOPROXIL FUMARATE+EFAVIRENZ are dizziness, headache, diarrhoea, nausea, vomiting, rashes (red spots or blotches, sometimes with blistering and swelling of the skin), and feeling weak. These side effects usually resolve without requiring any medical attention. However, if any of these side effects persist or worsen, inform your doctor immediately.
EMTRICITABINE+TENOFOVIR DISOPROXIL FUMARATE+EFAVIRENZ is not recommended to take EMTRICITABINE+TENOFOVIR DISOPROXIL FUMARATE+EFAVIRENZ if you are allergic to any contents of it. EMTRICITABINE+TENOFOVIR DISOPROXIL FUMARATE+EFAVIRENZ is not recommended for use in lactating mothers, children and adolescents under 18 years of age. EMTRICITABINE+TENOFOVIR DISOPROXIL FUMARATE+EFAVIRENZ may cause dizziness, so do not drive or operate heavy machinery if you feel dizzy. Consumption of alcohol may increase the risk of side effects; therefore, avoid alcohol consumption.
Uses of EMTRICITABINE+TENOFOVIR DISOPROXIL FUMARATE+EFAVIRENZ
Medicinal Benefits
EMTRICITABINE+TENOFOVIR DISOPROXIL FUMARATE+EFAVIRENZ belongs to the group of medicines called antiretroviral therapy. EMTRICITABINE+TENOFOVIR DISOPROXIL FUMARATE+EFAVIRENZ contains Emtricitabine, Tenofovir Disoproxil Fumarate and Efavirenz. EMTRICITABINE+TENOFOVIR DISOPROXIL FUMARATE+EFAVIRENZ works by inhibiting the reverse transcriptase enzyme production, which is necessary to multiply the viruses. This effect helps to inhibit viral replication and treats HIV infection.
Directions for Use
Storage
Side Effects of EMTRICITABINE+TENOFOVIR DISOPROXIL FUMARATE+EFAVIRENZ
- Dizziness
- Headache
- Diarrhoea
- Nausea
- Vomiting
- Rashes
- Feeling weak
- Loss of appetite
Patients Concern
Disease/Condition Glossary
HIV infection: HIV (human immunodeficiency virus) is a virus that attacks the immune system, making the individual susceptible to other conditions or illnesses. People with HIV experience flu-like symptoms such as fever, chills, rash, night sweats, muscle aches, tiredness, and sore throat. These symptoms usually last for days to several weeks. It spreads through body fluids such as semen, vaginal fluid, and blood. This condition can lead to AIDS (Acquired Immunodeficiency Syndrome). It is a life-long condition, and there is no definite cure. However, it can be controlled by treating it with antiretroviral agents.
FAQs
EMTRICITABINE+TENOFOVIR DISOPROXIL FUMARATE+EFAVIRENZ works by inhibiting the reverse transcriptase enzyme production, which is necessary for the production of viruses. This effect helps to inhibit viral replication and treats HIV infection.
EMTRICITABINE+TENOFOVIR DISOPROXIL FUMARATE+EFAVIRENZ is not recommended for patients with severe liver disease, moderate to severe kidney disease, or heart conditions such as prolonged QT interval, which increases the risk of severe heart rhythm problems, family history of heart problems, and low electrolyte levels.
EMTRICITABINE+TENOFOVIR DISOPROXIL FUMARATE+EFAVIRENZ doesn’t cure HIV infection. However, it helps to control the disease and prevent opportunistic infections.
EMTRICITABINE+TENOFOVIR DISOPROXIL FUMARATE+EFAVIRENZ may cause dizziness, drowsiness, difficulty sleeping, or difficulty concentrating in the first 1-2 days of treatment, and these symptoms generally go away after the first 2-4weeks. Therefore, avoid driving or operating machinery unless you are alert.
